Wallace, J. L., Nagy, P., Feener, T., Allain, T., Ditrói, T., Vaughan, D., . . . Buret, A. (2019). A3 A PROOF-OF-CONCEPT, PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF A HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346). J Can Assoc Gastroenterol.

Wallace, J L., P. Nagy, T. Feener, T. Allain, T. Ditrói, D. Vaughan, M. Muscara, G. de Nucci, e A. Buret. "A3 A PROOF-OF-CONCEPT, PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF A HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346)." J Can Assoc Gastroenterol 2019.

Wallace, J L., et al. "A3 A PROOF-OF-CONCEPT, PHASE 2 CLINICAL TRIAL OF THE GI SAFETY OF A HYDROGEN SULFIDE-RELEASING ANTI-INFLAMMATORY DRUG (ATB-346)." J Can Assoc Gastroenterol 2019.